The National Health Insurance Administration (NHIA) has decided to cover an expensive, but effective gene therapy for aromatic L-amino acid decarboxylase (AADC) deficiency, sparking debate over fairness and treatment access for patients with other rare conditions.
The one-time therapy, which costs about NT$100 million (US$3.28 million) per injection, would be covered on a temporary basis, the NHIA said on Tuesday.
Its effectiveness would be reassessed three years after treatment begins, and coverage terms may be adjusted as needed.
Photo: Taipei Times
AADC deficiency affects infants and young children, causing severe developmental delays and autonomic dysfunction.
Without treatment, many patients die between the ages of two and five, but the therapy can significantly improve motor function and quality of life.
The treatment was developed by National Taiwan University Hospital (NTUH) in 2007, with clinical protocols established in 2010 before being licensed to a US company.
The NHIA estimates that 13 patients would receive the therapy in its first year at a cost of about NT$1.3 billion.
From the second through fifth years, five additional patients are expected to be treated annually, costing about NT$500 million per year.
The decision has sparked criticism from physicians, including pulmonologist Su Yi-fong (蘇一峰), who said that drugs for other rare diseases — such as lymphangioleiomyomatosis (LAM or "bubble lung") — treat dozens of patients for less than NT$100 million, yet are not fully covered.
Supporters countered that the AADC therapy offers life-saving benefits and meaningful developmental gains.
Physician Chiang Kuan-yu (姜冠宇) said the investment could help position Taiwan as a key site for Asian genetic data, supporting future research collaborations and negotiations with international pharmaceutical companies.
NTUH Department of Medical Genetics director Chien Yin-hsiu (簡穎秀) defended the technology transfer to the US, saying few believed in the feasibility of AADC gene therapy two decades ago.
There had been no effective treatment for AADC deficiency in the past, and affected children could only lie immobile in bed with no motor development, Chien said.
Among the 31 patients who received the new therapy in a trial, 80 percent were able to sit up, and among those treated early with intensive rehabilitation, 40 percent were able to walk independently, she said.
"Just being able to sit up instead of only lying down makes an enormous difference," she said. "For parents providing daily care, the improvement is like night and day."
Regarding LAM coverage, NHIA Director-General Chen Lian-yu (陳亮妤) said the disease is not currently classified as rare, although applications have been submitted.
Coverage would follow once the ministry completes its review, she said.
LAM drugs have been covered under NHI since 2001, with 26 patients reported last year.
NHIA said it would assist families facing difficulties in the application process.
Nipah virus infection is to be officially listed as a category 5 notifiable infectious disease in Taiwan in March, while clinical treatment guidelines are being formulated, the Centers for Disease Control (CDC) said yesterday. With Nipah infections being reported in other countries and considering its relatively high fatality rate, the centers on Jan. 16 announced that it would be listed as a notifiable infectious disease to bolster the nation’s systematic early warning system and increase public awareness, the CDC said. Bangladesh reported four fatal cases last year in separate districts, with three linked to raw date palm sap consumption, CDC Epidemic Intelligence
The manufacture of the remaining 28 M1A2T Abrams tanks Taiwan purchased from the US has recently been completed, and they are expected to be delivered within the next one to two months, a source said yesterday. The Ministry of National Defense is arranging cargo ships to transport the tanks to Taiwan as soon as possible, said the source, who is familiar with the matter. The estimated arrival time ranges from late this month to early next month, the source said. The 28 Abrams tanks make up the third and final batch of a total of 108 tanks, valued at about NT$40.5 billion
Two Taiwanese prosecutors were questioned by Chinese security personnel at their hotel during a trip to China’s Henan Province this month, the Mainland Affairs Council (MAC) said yesterday. The officers had personal information on the prosecutors, including “when they were assigned to their posts, their work locations and job titles,” MAC Deputy Minister and spokesman Liang Wen-chieh (梁文傑) said. On top of asking about their agencies and positions, the officers also questioned the prosecutors about the Cross-Strait Joint Crime-Fighting and Judicial Mutual Assistance Agreement, a pact that serves as the framework for Taiwan-China cooperation on combating crime and providing judicial assistance, Liang
Reports of Taiwanese going missing, being detained or interrogated, or having their personal liberties restricted in China increased about fourfold annually last year, the Mainland Affairs Council (MAC) said yesterday. Last year, 221 Taiwanese who traveled to China were reported missing, were detained and interrogated, or otherwise had their personal freedom restricted, up from 55 the previous year, the council said. Reopening group tours to China would be risky, as it would leave travelers with no way to seek help through official channels after Beijing shut down dialogue between the associations tasked with handling cross-strait tourism, the MAC said. Taipei’s Taiwan Strait Tourism